Alamab Therapeutics Inc.

Biotechnology company · Princeton, New Jersey, United States

Alamab Therapeutics Inc. is a biotechnology company headquartered in Princeton, New Jersey, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $12 million sold in a notice filed in 2017.

Profile compiled from public records. Is this your company? Request a correction or update

Alamab Therapeutics at a glance

Typebiotechnology company

HeadquartersPrinceton, New Jersey, United States

Earliest incorporation on record2017

SEC CIK1713896

What does Alamab Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $11.8 million sold (2017).

Frequently asked questions about Alamab Therapeutics

Where is Alamab Therapeutics headquartered?

Alamab Therapeutics Inc. is headquartered in Princeton, New Jersey, United States.

What does Alamab Therapeutics do?

Alamab Therapeutics Inc. is a biotechnology company.

When was Alamab Therapeutics founded?

The earliest incorporation on record for Alamab Therapeutics Inc. is in 2017, according to public company registers.

Similar companies

Oyster Point Pharma, Inc.Princeton, New Jersey, United States
Optimeos Life Sciences, Inc.Princeton, New Jersey, United States
Santiste Medical Inc.Princeton, New Jersey, United States
Nanocan Therapeutics CorporationPrinceton, New Jersey, United States
Regenosine, Inc.Princeton, New Jersey, United States
Rhodenergy An Environmental Co CorpPrinceton, New Jersey, United States
Inaedis, IncPrinceton, New Jersey, United States
Recursion PharmaceuticalsSalt Lake City, Utah, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences